Last reviewed · How we verify
NCT06690749: Negative press
Using Skin Blood Flow to Measure the Effect of Different Doses of Negative Pressure Therapy
NA trial testing Negative pressure therapy, NPT in Hypertrophic Scars in 36 participants. Completed in 11 May 2023.
11 May 2023
Quick facts
| Lead sponsor | Asia University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 11 May 2022 |
| Primary completion | 11 May 2023 |
| Estimated completion | 11 May 2023 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Negative pressure therapy, NPT
Conditions studied
- Hypertrophic Scars — all drugs for Hypertrophic Scars →
Sponsor
Asia University
Who can join
18 and older, any sex, with Hypertrophic Scars. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction. Skin blood flow (SBF) is crucial for transporting nutrients during healing to treat scarring. Negative pressure therapy (NPT) is a promising option to enhance SBF. However, it is unclear what dosage of NPT is most effective in treating scars. This study compared NPT dosages of -105 mmHg, -125 mmHg, and -145 mmHg to assess the impact of NPT treatment on SBF in scar tissue and the correlation of NPT. If participants experience any symptoms of discomfort, NPT can be discontinued immediately. 36 scarred subjects were recruited to assess the efficacy of various NPT interventions. SBF applications are defined as perfusion levels instantly affecting NPT, and termination is defined as SBF after NPT. The study runs from May 11, 2022, to May 11, 2023, at Asia University Hospital. This study was funded by the National Science and Technology Council, Taiwan (NSTC 112-2221-E-468-004) The main contact was Chi-Wen Lung, the person in charge of a college or university department of Product Design, Asia University, Taichung 413305, Taiwan.Email address: cwlung@asia.edu.tw
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of Negative Pressure Therapy on Skin Blood Flow Responses in Scar Tissue.
Shen WC, Cheng HT, Jan YK, Liau BY, et al · · 2025 · cited 1× · PMID 40979006 · DOI 10.7759/cureus.90436
Verify or expand the search:
- PubMed search for NCT06690749
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Asia University trials
Trials by the same sponsor.
- NCT07426354 — Multimodal Sensory Feedback and Mirror Therapy for Stroke Rehabilitation · NA · enrolling by invitation
- NCT06827925 — Telemedicine Wounds · NA · not yet recruiting
- NCT06527716 — Digital Multimedia in Clinical Nurse Education for Pressure Injury Prevention Via LINE@ · NA · not yet recruiting
- NCT07177274 — Evaluation of Skin Stiffness Changes in Wounds Before and After Low-Level Laser Therapy · NA · active not recruiting
- NCT07366073 — Effects of Virtual Reality Dementia Education on College Students' Knowledge and Attitudes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06690749 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asia University
- Last refreshed: 15 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06690749.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing